Martin A. Smith

Martin A. Smith

Auto-generated profile, based on publicly available information

Martin A. Smith

Faculty of Science Ramaciotti Centre for Genomics School of Biotechnology and Biomolecular Sciences UNSW Sydney Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Cell
Verified
Journal Article
Closed access
TMTim R. Mercer
Tim R. Mercer
SNShane Neph
Shane Neph
Marcel DingerMarcel Dinger
Marcel Dinger
JCJoanna Crawford
Joanna Crawford
MSMartin A. Smith
Martin A. Smith
JMJohn Mattick
John Mattick

1 May 2016 in Cell
Verified
Journal Article
Closed access
ZLZhipeng Lu
Zhipeng Lu
QZQiangfeng Cliff Zhang
Qiangfeng Cliff Zhang
BLByron Lee
Byron Lee
RFRyan A. Flynn
Ryan A. Flynn
MSMartin A. Smith
Martin A. Smith
HCHoward Y. Chang
Howard Y. Chang

30 August 2017 in RNA
Verified
Journal Article
Open access
PDF file
NJNicky Jonkhout
Nicky Jonkhout
JTJulia Tran
Julia Tran
MSMartin A. Smith
Martin A. Smith
NSNicole Schonrock
Nicole Schonrock
JMJohn Mattick
John Mattick
ENEva Maria Novoa
Eva Maria Novoa
RNA modifications have been historically considered as fine-tuning chemo-structural features of infrastructural RNAs, such as rRNAs, tRNAs, and snoRNAs. This view has changed dramatically in recent years, to a large extent as a result of systematic efforts to map and quantify various RNA modifications in a transcriptome-wide manner, revealing that RNA modifications are reversible, dynamically regulated, far more widespread than originally thought, and involved in major biological processes, including cell differentiation, sex determination, and stress responses. Here we summarize the state of knowledge and provide a catalog of RNA modifications and their links to neurological disorders, cancers, and other diseases. With the advent of direct RNA-sequencing technologies, we expect that this catalog will help prioritize those RNA modifications for transcriptome-wide maps.

9 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHuanle Liu
Huanle Liu
OBOguzhan Begik
Oguzhan Begik
MLMorghan C. Lucas
Morghan C. Lucas
JRJose Miguel Ramirez
Jose Miguel Ramirez
Christopher MasonChristopher Mason
Christopher Mason
ENEva Maria Novoa
Eva Maria Novoa
The epitranscriptomics field has undergone an enormous expansion in the last few years; however, a major limitation is the lack of generic methods to map RNA modifications transcriptome-wide. Here, we show that using direct RNA sequencing, N6-methyladenosine (m6A) RNA modifications can be detected with high accuracy, in the form of systematic errors and decreased base-calling qualities. Specifically, we find that our algorithm, trained with m6A-modified and unmodified synthetic sequences, can predict m6A RNA modifications with ~90% accuracy. We then extend our findings to yeast data sets, finding that our method can identify m6A RNA modifications in vivo with an accuracy of 87%. Moreover, we further validate our method by showing that these ‘errors’ are typically not observed in yeast ime4-knockout strains, which lack m6A modifications. Our results open avenues to investigate the biological roles of RNA modifications in their native RNA context.

31 May 2011 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DKDivya Khaitan
Divya Khaitan
Marcel DingerMarcel Dinger
Marcel Dinger
JMJoseph Mazar
Joseph Mazar
JCJoanna Crawford
Joanna Crawford
MSMartin A. Smith
Martin A. Smith
RPRanjan J. Perera
Ranjan J. Perera
The identification of cancer-associated long noncoding RNAs (lncRNAs) and the investigation of their molecular and biological functions are important to understand the molecular biology of cancer and its progression. Although the functions of lncRNAs and the mechanisms regulating their expression are largely unknown, recent studies are beginning to unravel their importance in human health and disease. Here, we report that a number of lncRNAs are differentially expressed in melanoma cell lines in comparison to melanocytes and keratinocyte controls. One of these lncRNAs, SPRY4-IT1 (GenBank accession ID AK024556), is derived from an intron of the SPRY4 gene and is predicted to contain several long hairpins in its secondary structure. RNA-FISH analysis showed that SPRY4-IT1 is predominantly localized in the cytoplasm of melanoma cells, and SPRY4-IT1 RNAi knockdown results in defects in cell growth, differentiation, and higher rates of apoptosis in melanoma cell lines. Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma. The elevated expression of SPRY4-IT1 in melanoma cells compared to melanocytes, its accumulation in cell cytoplasm, and effects on cell dynamics, including increased rate of wound closure on SPRY4-IT1 overexpression, suggest that the higher expression of SPRY4-IT1 may have an important role in the molecular etiology of human melanoma. Cancer Res; 71(11); 3852–62. ©2011 AACR.

1 April 2011 in RNA
Verified
Journal Article
Closed access
PDF file
MAMarjan Askarian-Amiri
Marjan Askarian-Amiri
JCJoanna Crawford
Joanna Crawford
JFJuliet D. French
Juliet D. French
CSChanel E. Smart
Chanel E. Smart
MSMartin A. Smith
Martin A. Smith
JMJohn Mattick
John Mattick
Long noncoding RNAs (lncRNAs) are increasingly recognized to play major regulatory roles in development and disease. To identify novel regulators in breast biology, we identified differentially regulated lncRNAs during mouse mammary development. Among the highest and most differentially expressed was a transcript (Zfas1) antisense to the 5′ end of the protein-coding gene Znfx1. In vivo, Zfas1 RNA is localized within the ducts and alveoli of the mammary gland. Zfas1 intronically hosts three previously undescribed C/D box snoRNAs (SNORDs): Snord12, Snord12b, and Snord12c. In contrast to the general assumption that noncoding SNORD-host transcripts function only as vehicles to generate snoRNAs, knockdown of Zfas1 in a mammary epithelial cell line resulted in increased cellular proliferation and differentiation, while not substantially altering the levels of the SNORDs. In support of an independent function, we also found that Zfas1 is extremely stable, with a half-life >16 h. Expression analysis of the SNORDs revealed these were expressed at different levels, likely a result of distinct structures conferring differential stability. While there is relatively low primary sequence conservation between Zfas1 and its syntenic human ortholog ZFAS1, their predicted secondary structures have similar features. Like Zfas1, ZFAS1 is highly expressed in the mammary gland and is down-regulated in breast tumors compared to normal tissue. We propose a functional role for Zfas1/ ZFAS1 in the regulation of alveolar development and epithelial cell differentiation in the mammary gland, which, together with its dysregulation in human breast cancer, suggests ZFAS1 as a putative tumor suppressor gene.